Detalhe da pesquisa
1.
Epigenomic machinery regulating pediatric AML: Clonal expansion mechanisms, therapies, and future perspectives.
Semin Cancer Biol
; 92: 84-101, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37003397
2.
How I manage CLL with venetoclax-based treatments.
Blood
; 135(17): 1421-1427, 2020 04 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-32076705
3.
Cancer epigenetics: Moving forward.
PLoS Genet
; 14(6): e1007362, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29879107
4.
Antiemetic prophylaxis in patients undergoing hematopoietic stem cell transplantation: a multicenter survey of the Gruppo Italiano Trapianto Midollo Osseo (GITMO) transplant programs.
Ann Hematol
; 99(4): 867-875, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32036421
5.
Eradication of bone marrow minimal residual disease may prompt early treatment discontinuation in CLL.
Blood
; 123(24): 3727-32, 2014 Jun 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-24705492
6.
Cytokine release syndrome and complete remission of extra medullary acute lymphoblastic leukemia of the breast with CAR-T and radiation therapy.
Pediatr Blood Cancer
; 68(5): e28839, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33258192
7.
Outcomes of first-line treatment for chronic lymphocytic leukemia with 17p deletion.
Haematologica
; 99(8): 1350-5, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24859876
8.
Long-Term Complications after Allogeneic Hematopoietic Stem Cell Transplantation with Treosulfan- or Busulfan-Based Conditioning in Pediatric Patients with Acute Leukemia or Myelodysplastic Syndrome: Results of an Associazione Italiana Ematologia Oncologia Pediatrica Retrospective Study.
Transplant Cell Ther
; 30(4): 433.e1-433.e10, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38176654
9.
Cytogenetic abnormalities predict survival after allogeneic hematopoietic stem cell transplantation for pediatric acute myeloid leukemia: a PDWP/EBMT study.
Bone Marrow Transplant
; 59(4): 451-458, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38225386
10.
Last Trends in Point-of-Care (POC) Diagnostics for the Management of Hematological Indices in Home Care Patients.
Biosensors (Basel)
; 13(3)2023 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36979557
11.
Rare solid tumors in a patient with Wiskott-Aldrich syndrome after hematopoietic stem cell transplantation: case report and review of literature.
Front Immunol
; 14: 1229674, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37781361
12.
High-Risk Acute Myeloid Leukemia: A Pediatric Prospective.
Biomedicines
; 10(6)2022 Jun 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35740427
13.
A multicenter study of ICU resource utilization in pediatric, adolescent and young adult patients post CAR-T therapy.
Front Oncol
; 12: 1022901, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36353531
14.
The Role of BTK Inhibition in the Treatment of Chronic Lymphocytic Leukemia: A Clinical View.
J Exp Pharmacol
; 13: 923-935, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34744463
15.
Pneumatosis cystoides intestinalis, a rare case in a pediatric patient following allogeneic hematopoietic stem cell transplantation: CT findings and literature review.
Radiol Case Rep
; 16(10): 3120-3124, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34457100
16.
The TKI Era in Chronic Leukemias.
Pharmaceutics
; 13(12)2021 Dec 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34959482
17.
Immune Effector Cell Associated Neurotoxicity (ICANS) in Pediatric and Young Adult Patients Following Chimeric Antigen Receptor (CAR) T-Cell Therapy: Can We Optimize Early Diagnosis?
Front Oncol
; 11: 634445, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33763368
18.
Diagnosis, grading and management of toxicities from immunotherapies in children, adolescents and young adults with cancer.
Nat Rev Clin Oncol
; 18(7): 435-453, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33608690
19.
Tumour lysis syndrome in patients with chronic lymphocytic leukaemia treated with BCL-2 inhibitors: risk factors, prophylaxis, and treatment recommendations.
Lancet Haematol
; 7(2): e168-e176, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-32004486
20.
Complete remission in refractory acute lymphoblastic leukemia using blinatumomab after failure of response to CD-19 chimeric antigen receptor T-cell therapy.
Clin Case Rep
; 8(9): 1678-1681, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32983475